Fingerprint
Dive into the research topics of 'Extending venous thromboembolism secondary prevention with apixaban in cancer patients: The EVE trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Extending venous thromboembolism secondary prevention with apixaban in cancer patients: The EVE trial
Robert D. McBane, Charles L. Loprinzi, Aneel Ashrani, Charles J. Lenz, Damon Houghton, Tyler Zemla, Jennifer G. Le-Rademacher, Waldemar E. Wysokinski
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations